Cerenome (PSTV) Gains from Investment Securities (2015 - 2024)
Plus Therapeutics (PSTV) posted quarterly Gains from Investment Securities of -$960000.0 for Q3 2024, up 79.55% quarter-over-quarter from -$4.7 million in Q2 2024.
Cerenome (PSTV) Gains from Investment Securities (2015 - 2024) Analysis & Trends
Plus Therapeutics (PSTV) has reported Gains from Investment Securities for 7 consecutive years, with -$960000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Gains from Investment Securities changed N/A year-over-year to -$960000.0; the TTM figure through Dec 2024 stood at -$5.7 million (changed N/A YoY), while the FY2024 annual figure was -$5.7 million, changed N/A from the prior year.
- Gains from Investment Securities rose to -$960000.0 in Q3 2024 per PSTV's latest filing, from -$4.7 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $81000.0 in Q3 2020 and bottomed at -$4.7 million in Q2 2024.
- Historically, Gains from Investment Securities has averaged -$806100.0 across 4 years, with a median of -$30000.0 in 2020.
- Annual changes were most pronounced in 2020 — Gains from Investment Securities slumped 693.81% — and 2021, when it soared 99.88%.
- Plus Therapeutics' Gains from Investment Securities stood at -$58000.0 in 2020, then jumped by 96.55% to -$2000.0 in 2021, then jumped by 50.0% to -$1000.0 in 2022, then tumbled by 95900.0% to -$960000.0 in 2024.
- Business Quant data shows PSTV's Gains from Investment Securities at -$960000.0 in Q3 2024, -$4.7 million in Q2 2024, and -$1000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -960,000.00 |
| Sep 30, 2024 | -960,000.00 |
| Jun 30, 2024 | -4.69 Mn |
| Jun 30, 2024 | -4.69 Mn |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -58,000.00 |
| Dec 31, 2020 | -58,000.00 |
| Sep 30, 2020 | 81,000.00 |
| Sep 30, 2020 | 81,000.00 |
| Jun 30, 2020 | -756,000.00 |
| Jun 30, 2020 | -756,000.00 |
| Mar 31, 2020 | -1.67 Mn |
| Mar 31, 2020 | -1.67 Mn |